Collaborating for the Future: EUCROF Welcomes Four New Executive Board Members at Sofia General Assembly
European Leaders Align on Research Goals in Sofia
SOFIA, BULGARIA — The European Clinical Research Organisation Federation (EUCROF) successfully concluded its Spring General Assembly, held in Sofia on 4–5 June 2026. Hosted and supported by the Rosenbaum Group, the two-day event served as a vital forum for members to align strategic priorities, review organisational impact, and plan upcoming initiatives.
Regulatory Insights & Opening Frameworks
The event commenced with a deep dive into local and European clinical trial landscapes. Dr Boyan Doganov, Deputy Chairman of the Ethics Committee for Clinical Trials in Bulgaria, delivered an insightful presentation on the regulatory and ethical frameworks governing regional clinical research.
Four Strategic Pillars for Europe
Following these initial high-level discussions, the assembly established four critical focus areas:
Boosting Competitiveness: Implementing active strategies to position Europe as a premier global hub for clinical trials.
Raising Patient Awareness: Educating the public regarding the profound, life-changing benefits of participating in clinical research.
Optimising Engagement: Refining and scaling existing patient engagement programmes across Europe to improve trial retention and experience.
Deploying GDPR Standards: Implementing the newly approved GDPR Code of Conduct for clinical research—a vital compliance milestone driven directly by EUCROF members.
Steering the Federation’s Future
A major highlight of the assembly was the interim election of four new members to the EUCROF Executive Board. The federation is delighted to welcome:
Doris Neuhauser
Evangelia (Lia) Koraki
Jean-Sébastien Gosuin
Philip Raeth
These newly elected leaders will play a pivotal role in shaping EUCROF's future activities, governance, and long-term strategic direction.
Interview with Dr Cristina Florescu Moraid
During the assembly, Dr Cristina Florescu Moraid shared crucial insights straight from the venue regarding Romania's expanding role in the European clinical trials ecosystem:
"As a proud full member since 2019, Romania is actively collaborating with European leaders to shape the future of clinical research. During this assembly, we tackled critical strategies to boost Europe's competitiveness and make our continent a premier hub for clinical trials; raise patient awareness regarding the profound benefits of participating in clinical trials; optimise existing patient engagement programmes across Europe; and implement the new GDPR Code of Conduct for clinical research—a vital initiative driven by EUCROF members. Moving forward, our focus is clear: stronger communication between EU Member States. By uniting our efforts, we shall provide the expertise and support that biotech and pharmaceutical companies require to deliver innovative treatments to patients more swiftly."
Looking Ahead & Additional Activities
Advanced preparations and strategic planning discussions centred heavily on the highly anticipated EUCROF27 conference. Additional key activities during the assembly included:
Working Group Showcases: Specialised presentations highlighting collaborative cross-federation expertise.
Governance Updates: Financial reviews and administrative adjustments to support continued growth.
For further details regarding federation initiatives or to explore upcoming events, please visit the official EUCROF website.
